What is Haemonetics's common stock?

Haemonetics (HAE) reported common stock of $453K in Q1 2026.

How has Haemonetics's common stock changed year-over-year?

Haemonetics's common stock decreased by 6.0% year-over-year, from $482K to $453K.

What is the long-term trend for Haemonetics's common stock?

Over 5 years (2021 to 2026), Haemonetics's common stock has grown at a -2.3% compound annual growth rate (CAGR), from $509K to $453K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Haemonetics HAE Common Stock

Common Stock at other companies

TFX

TeleflexTFX

$48.2M+0.2%

MedtronicMDT

$0—

LivaNovaLIVN

$84.56M+0.1%

ICU MedicalICUI

80M0.0%

Merit Medical SystemsMMSI

$769.27M+7.1%

DanaherDHR

2B+22,122%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's common stock?: Haemonetics (HAE) reported common stock of $453K in Q1 2026.
How has Haemonetics's common stock changed year-over-year?: Haemonetics's common stock decreased by 6.0% year-over-year, from $482K to $453K.
What is the long-term trend for Haemonetics's common stock?: Over 5 years (2021 to 2026), Haemonetics's common stock has grown at a -2.3% compound annual growth rate (CAGR), from $509K to $453K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).